GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer.

Cancer Cell Int · 2023 · PMC10617133 · PMID 37904122

Europe PMC DOI

hedged sentences

0.1590

closest p · 3.2× alpha

0.1590

boldest claim

The sentences

showed a trendp = 0.159not close (p > 0.1)

However, patients with increased mutations showed a trend toward poor PFI (p = 0.159) (Fig. 4 F).

also in 53,322 other papers

an increasing trendno p-value reported

Finally, with the help of the human protein atlas database (HPA) database ( https://www.proteinatlas.org ), GAD1 expression was confirmed to show an increasing trend in prostate tissue (Fig. 7 N), high-grade prostate cancer (Fig. 7 O), as well as low-grade prostate cancer (Fig. 7 P), which was consistent with GAD1 expression in different grade (Fig. 3 F).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.